AbbVie Inc. is 143.8x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($397.44 B vs $2.76 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SLNO | ABBV |
|---|---|---|
| Market cap | $2.76 B | $397.44 B |
| US-listed rank | #1873 | #28 |
| Revenue (latest FY) | $190.41M | $61.16B |
| Net income (latest FY) | $20.89M | $4.23B |
| Net margin | 11.0% | 6.9% |
| P/E (trailing FY) | 132.3 | 94.0 |
| SEC filings | 1,119 | 1,008 |
AbbVie Inc. is 143.8x more valuable than SOLENO THERAPEUTICS INC by market capitalization ($397.44 B vs $2.76 B).
In their latest fiscal years, SOLENO THERAPEUTICS INC reported $190.41M in revenue while AbbVie Inc. reported $61.16B.
Full pages: SOLENO THERAPEUTICS INC and AbbVie Inc., or browse the full rankings.